These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27203818)

  • 1. A population study of respiratory rehospitalisation in very preterm infants in the first 3 years of life.
    Hong T; Bolisetty S; Bajuk B; Abdel-Latif M; Oei J; Jaffe A; Lui K
    J Paediatr Child Health; 2016 Jul; 52(7):715-21. PubMed ID: 27203818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea.
    Lee JH; Kim CS; Chang YS; Choi JH;
    J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S104-10. PubMed ID: 26566351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age.
    Resch B; Pasnocht A; Gusenleitner W; Müller W
    J Infect; 2005 Jun; 50(5):397-403. PubMed ID: 15907547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home Oxygen Use and 1-Year Readmission among Infants Born Preterm with Bronchopulmonary Dysplasia Discharged from Children's Hospital Neonatal Intensive Care Units.
    Lagatta J; Murthy K; Zaniletti I; Bourque S; Engle W; Rose R; Ambalavanan N; Brousseau D
    J Pediatr; 2020 May; 220():40-48.e5. PubMed ID: 32093927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rehospitalization for respiratory syncytial virus among premature infants.
    Joffe S; Escobar GJ; Black SB; Armstrong MA; Lieu TA
    Pediatrics; 1999 Oct; 104(4 Pt 1):894-9. PubMed ID: 10506231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area.
    Deshpande SA; Northern V
    Arch Dis Child; 2003 Dec; 88(12):1065-9. PubMed ID: 14670770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community and nosocomially acquired respiratory syncytial virus infection in a German paediatric hospital from 1988 to 1999.
    Berner R; Schwoerer F; Schumacher RF; Meder M; Forster J
    Eur J Pediatr; 2001 Sep; 160(9):541-7. PubMed ID: 11585076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epidemiological investigation of high-risk infants for Respiratory Syncytial Virus infections: a retrospective cohort study.
    Servadio M; Finocchietti M; Vassallo C; Cipelli R; Heiman F; Di Lucchio G; Oresta B; Addis A; Belleudi V
    Ital J Pediatr; 2024 Mar; 50(1):56. PubMed ID: 38528568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Hemming VG
    Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.
    Liese JG; Grill E; Fischer B; Roeckl-Wiedmann I; Carr D; Belohradsky BH;
    Eur J Pediatr; 2003 Apr; 162(4):230-6. PubMed ID: 12647195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does chronic oxygen dependency in preterm infants with bronchopulmonary dysplasia at NICU discharge predict respiratory outcomes at 3 years of age?
    Lodha A; Ediger K; Rabi Y; Lodha S; Tang S; Bhandari A; Sauve R; Bhandari V
    J Perinatol; 2015 Jul; 35(7):530-6. PubMed ID: 25719546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes among Diagnostic Subgroups of Infants with Severe Bronchopulmonary Dysplasia through 2 Years of Age.
    Akangire G; Manimtim W; Nyp MF; Noel-MacDonnell J; Kays AN; Truog WE; Taylor JB
    Am J Perinatol; 2018 Dec; 35(14):1376-1387. PubMed ID: 29852508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory morbidity was an important consequence of prematurity in the first two years after discharge in three cohorts from 1996 to 2009.
    Mulder EEM; Rijken M; de Smet L; Pauws S; Lopriore E; Te Pas AB
    Acta Paediatr; 2018 Jan; 107(1):68-72. PubMed ID: 28940731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge: A 3-year follow-up.
    Nachman SA; Navaie-Waliser M; Qureshi MZ
    Pediatrics; 1997 Dec; 100(6):E8. PubMed ID: 9382909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of rehospitalisation in the first 2 years among preterm infants discharged from the NICU of a tertiary children hospital in Vietnam: a follow-up study.
    Do CHT; Børresen ML; Pedersen FK; Geskus RB; Kruse AY
    BMJ Open; 2020 Oct; 10(10):e036484. PubMed ID: 33020086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe respiratory syncytial virus bronchiolitis: epidemiologic variations associated with the initiation of palivizumab in severely premature infants with bronchopulmonary dysplasia.
    Grimaldi M; Gouyon B; Michaut F; Huet F; Gouyon JB;
    Pediatr Infect Dis J; 2004 Dec; 23(12):1081-5. PubMed ID: 15626942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Respiratory morbidity after hospital discharge in premature infants born at < or = 32 weeks gestation with bronchopulmonary dysplasia].
    Pérez Pérez G; Navarro Merino M; Romero Pérez MM; Sáenz Reguera C; Pons Tubío A; Polo Padillo J
    An Pediatr (Barc); 2004 Feb; 60(2):117-24. PubMed ID: 14757014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia.
    Mowitz ME; Mangili A; Han L; Ayyagari R; Gao W; Wang J; Zhao J; Sarda SP
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1117-1125. PubMed ID: 33236680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.